tiprankstipranks
Trending News
More News >
Scpharmaceuticals (SCPH)
:SCPH
US Market
Advertisement

scPharmaceuticals (SCPH) Stock Forecast & Price Target

Compare
Followers
See the Price Targets and Ratings of:

SCPH Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
scPharmaceuticals
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SCPH Stock 12 Month Forecast

There Are No Analyst Ratings for SCPH In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

SCPH Financial Forecast

SCPH Earnings Forecast

Next quarter’s earnings estimate for SCPH is -$0.24 with a range of -$0.26 to -$0.23. The previous quarter’s EPS was -$0.34. SCPH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year SCPH has its overall industry.
Next quarter’s earnings estimate for SCPH is -$0.24 with a range of -$0.26 to -$0.23. The previous quarter’s EPS was -$0.34. SCPH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year SCPH has its overall industry.

SCPH Sales Forecast

Next quarter’s sales forecast for SCPH is $19.21M with a range of $18.80M to $19.53M. The previous quarter’s sales results were $16.04M. SCPH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year SCPH has its overall industry.
Next quarter’s sales forecast for SCPH is $19.21M with a range of $18.80M to $19.53M. The previous quarter’s sales results were $16.04M. SCPH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year SCPH has its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on SCPH
H.C. Wainwright
H.C. Wainwright
$18$5.35
Hold
Downgraded
08/29/25
scPharmaceuticals downgraded to Neutral from Buy at H.C. WainwrightscPharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
Craig-Hallum
$12$6
Hold
Downgraded
08/26/25
Craig-Hallum Reaffirms Their Buy Rating on scPharmaceuticals (SCPH)
Maxim Group Analyst forecast on SCPH
Maxim Group
Maxim Group
Hold
Downgraded
08/26/25
scPharmaceuticals downgraded to Hold from Buy at MaximscPharmaceuticals downgraded to Hold from Buy at Maxim
Leerink Partners Analyst forecast on SCPH
Leerink Partners
Leerink Partners
$11
Buy
Reiterated
08/11/25
Strong Market Presence and Strategic Advancements Drive Buy Rating for scPharmaceuticals
TD Cowen Analyst forecast on SCPH
TD Cowen
TD Cowen
$25
Buy
Reiterated
08/07/25
Promising Outlook for scPharmaceuticals: Buy Rating Supported by Strong Furoscix Demand and Strategic Growth Initiatives
Jefferies
$16$13
Buy
Reiterated
12/02/24
scPharmaceuticals (SCPH) PT Lowered to $13 at JefferiesJefferies analyst Glen Santangelo lowered the price target on scPharmaceuticals (NASDAQ: SCPH) to $13.00 (from $16.00) while maintaining a Buy rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on SCPH
H.C. Wainwright
H.C. Wainwright
$18$5.35
Hold
Downgraded
08/29/25
scPharmaceuticals downgraded to Neutral from Buy at H.C. WainwrightscPharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
Craig-Hallum
$12$6
Hold
Downgraded
08/26/25
Craig-Hallum Reaffirms Their Buy Rating on scPharmaceuticals (SCPH)
Maxim Group Analyst forecast on SCPH
Maxim Group
Maxim Group
Hold
Downgraded
08/26/25
scPharmaceuticals downgraded to Hold from Buy at MaximscPharmaceuticals downgraded to Hold from Buy at Maxim
Leerink Partners Analyst forecast on SCPH
Leerink Partners
Leerink Partners
$11
Buy
Reiterated
08/11/25
Strong Market Presence and Strategic Advancements Drive Buy Rating for scPharmaceuticals
TD Cowen Analyst forecast on SCPH
TD Cowen
TD Cowen
$25
Buy
Reiterated
08/07/25
Promising Outlook for scPharmaceuticals: Buy Rating Supported by Strong Furoscix Demand and Strategic Growth Initiatives
Jefferies
$16$13
Buy
Reiterated
12/02/24
scPharmaceuticals (SCPH) PT Lowered to $13 at JefferiesJefferies analyst Glen Santangelo lowered the price target on scPharmaceuticals (NASDAQ: SCPH) to $13.00 (from $16.00) while maintaining a Buy rating.
Stocks with the Highest Top Analyst Consensus in the Sector
Find stocks in the sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering scPharmaceuticals

1 Month
xxx
Success Rate
9/18 ratings generated profit
50%
Average Return
+3.28%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +3.28% per trade.
3 Months
xxx
Success Rate
9/18 ratings generated profit
50%
Average Return
+5.87%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +5.87% per trade.
1 Year
Roanna RuizLeerink Partners
Success Rate
8/18 ratings generated profit
44%
Average Return
+2.52%
reiterated a buy rating 2 months ago
Copying Roanna Ruiz's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of +2.52% per trade.
2 Years
xxx
Success Rate
10/18 ratings generated profit
56%
Average Return
+7.29%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 55.56% of your transactions generating a profit, with an average return of +7.29% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SCPH Analyst Recommendation Trends

Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
10
13
6
5
5
Buy
5
5
1
2
2
Hold
4
5
5
7
13
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
23
12
14
20
In the current month, SCPH has received 7 Buy Ratings, 13 Hold Ratings, and 0 Sell Ratings. SCPH average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

SCPH Stock Forecast FAQ

What is SCPH’s average 12-month price target, according to analysts?
Currently, no data Available
What is SCPH’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SCPH, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is SCPH a Buy, Sell or Hold?
      Currently, no data Available
      What is Scpharmaceuticals’s price target?
      Currently, no data Available
      What do analysts say about Scpharmaceuticals?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of SCPH?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis